http://www.naturalnews.com/z023324.html
Tamiflu Vaccine Linked With Convulsions, Delirium and Bizarre Deaths
by David Gutierrez
(NaturalNews) An FDA advisory panel has recommended stronger warnings on
two
influenza drugs after reviewing evidence linking them to neurological and
psychiatric problems that have led to deaths in some cases.
The current warning on Roche Laboratories' Tamiflu (generic name
oseltamivir) urges close monitoring of flu patients, particularly
children,
for "increased risk of self injury and confusion shortly after taking
Tamiflu." The panel recommended that this warning be strengthened to say
that "in some cases, these behaviors resulted in serious injuries,
including
death, in adult and pediatric patients."
The label of Glaxo SmithKline's Relenza (generic name zanamivir), the
panel
said, should be strengthened to mention "re****ts of hallucinations,
delirium
and abnormal behavior." The panel said that both labels should mention
that
some flu patients not taking the drugs have also experienced such
symptoms.
There have been no re****ted deaths from Tamiflu in the United States, but
in
Japan, where the drug is much more widely used, at least 14 deaths have
been
re****ted. Five children under the age of 17 died after "falling from
windows
or balconies or running into traffic," according to the FDA. According to
Roche, two people under the age of 21 died from a brain infection, and
seven
deaths from neuropsychiatric symptoms have also been attributed to use of
the drug by adults.
Since Tamiflu's introduction in 1999, a total of 48 million prescriptions
have been written, 75 percent of them in Japan. According to Roche, 1,745
of
1,808 re****ts of side effects came from Japan.
The FDA has noted that people in Japan appear to be more likely to re****t
side effects than people in the United States.
In March, Japan issued a warning against prescribing Tamiflu to people
between the ages of 10 and 19, and South Korea followed suit a month later
with a warning against use by teenagers.
|
